Market Research Report: Profundus AB
Company Overview
Name:
Profundus AB
Mission of the Company:
Profundus AB is dedicated to developing a novel fundus camera and software system aimed at the early detection, prevention, and treatment of various diseases through identification of changes in retinal microstructures. Their mission not only focuses on innovation in retinal imaging diagnostics but also aims to enhance patient quality of life worldwide.
Foundation:
- Founded by: Jörgen Thaung, Zoran Popovic, Associate Professor Mette Owner-Petersen, and PhD candidate Per Knutsson.
- Foundation Origin: The collaboration originated from their collective research efforts at the University of Gothenburg and Lund University.
Headquarters:
- Location: AstraZeneca BioVentureHub, Pepparredsleden 1, 431 83 Mölndal, Sweden
Key People in the Company:
- Åsa Lindström - CEO
- Zoran Popovic - Founder & Chief Scientific Officer
- Jörgen Thaung - Founder
- Matti Ahlqvist - Chairman of the Board, Executive Director, Gothenburg Site AstraZeneca
- Jan Erik Smith - Partner, Gobia Enterprises AB
- Ulrika Ågren - Investment Manager, Almi Invest
- David Sonnek - CEO, Navigare Ventures AB
- Elisabeth Gustafsson - Business Developer, GU Ventures
Number of Employees:
- 11 professionals
Revenue:
- No information is available
Known For:
Profundus AB is renowned for its groundbreaking breakthroughs in retinal imaging technology, particularly adapting advanced adaptive optics originally from astronomical applications, for enhanced retinal diagnostics.
Products
Overview:
Profundus focuses on retinal imaging technology, specifically through their innovative use of adaptive optics in their camera systems.
The Profundus Camera:
- High-resolution Retinal Imaging:
- Achieves up to 10 times higher resolution than conventional retinal imaging technology with a fundamental resolution of 2-3 µm.
- Wide-Field Imaging:
- Provides up to 8x larger field of view compared to devices using single-conjugate adaptive optics.
- Advanced Adaptive Optics System:
- Originates from astronomical technology used to correct atmospheric distortions and optimized for clinical applications.
- Key Features:
- Stand-alone system optimized for research and clinical use.
- Minimizes chair time, enhancing efficiency for operators and patients.
- Ease of use with minimal training requirements.
- Add-on software modules facilitating system growth.
- Supports efficient workflow in clinical environments.
Recent Developments
Recent Company Developments:
- August 2023: Matti Ahlqvist appointed as new Chairman of the Board.
- September 2023: Profundus and the University of Liverpool sign a Letter of Intent for the delivery of cameras and academic partnership.
New Product Launches:
- No information is available
New Features Added to Existing Products:
- No information is available
Partnerships and Alliances:
- May 2023: Received a Letter of Interest from Rigshospitalet in Glostrup, Denmark.
- Collaborations with university hospitals across the Nordics and plans for further investigation underlined by various Letters of Intent.
Financial Developments
- May 29, 2024: Profundus received a significant investment of 30 MSEK led by Navigare Ventures and Gobia Enterprises.
Scientific Endeavors:
Profundus is involved in cutting-edge retinal research supported by foundational work initiated between 2008 and 2018, backed by the Marcus and Amalia Wallenberg Memorial Fund and VINNOVA, the Swedish Government Innovation Agency. This underscores their commitment to advancing clinical relevance in comparison with established clinical methodologies.
Conclusion
Profundus AB continues to make significant strides within the retinal imaging sphere, using innovative applications of adaptive optics to push forward medical diagnostics technology. By leveraging their extensive research history and strategic partnerships, Profundus aims to enhance the early detection, treatment, and overall management of retinal and systemic diseases.
